Regions :: Southeast Asia :: Singapore
Novartis Plans Major Bio Plant
12:03 PM MST | November 9, 2007 | Chemical Week Editorial Staff
Novartis says it will spend about $700 million to build a biopharmaceutical drug manufacturing plant in Singapore. The planned facility will produce monoclonal antibody drugs designed to treat a range of diseases including cancers and rheumatoid arthritis. Novartis plans to start up the facility, which would feature a reactor larger than any in the company’s existing portfolio, in...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee